Its expression was significantly low in cervical cancer, and the expression level was negatively correlated with overall survival rate, tumor size and FIGO stage, while high expression of ZNF667-AS1 could reduce the proliferation and clonal ability of cervical cancer cells [16] (Fig. 1d). Here, ZNF667 is linked to cervical cancer.